Addus HomeCare Co. (NASDAQ:ADUS – Free Report) – Equities researchers at William Blair upped their Q3 2025 EPS estimates for Addus HomeCare in a research note issued on Thursday, December 19th. William Blair analyst J. Haase now forecasts that the company will earn $1.37 per share for the quarter, up from their previous estimate of $1.25. The consensus estimate for Addus HomeCare’s current full-year earnings is $4.59 per share.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same period last year, the business posted $1.03 EPS. The company’s revenue was up 7.1% compared to the same quarter last year.
Read Our Latest Stock Analysis on Addus HomeCare
Addus HomeCare Price Performance
Addus HomeCare stock opened at $128.86 on Monday. Addus HomeCare has a one year low of $85.94 and a one year high of $136.12. The business’s fifty day moving average is $125.80 and its 200 day moving average is $125.23. The stock has a market capitalization of $2.34 billion, a PE ratio of 29.49, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02.
Insiders Place Their Bets
In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.
Institutional Investors Weigh In On Addus HomeCare
Institutional investors and hedge funds have recently bought and sold shares of the business. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Addus HomeCare during the 3rd quarter valued at approximately $1,622,000. Dimensional Fund Advisors LP raised its position in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after buying an additional 5,421 shares during the last quarter. Point72 Asset Management L.P. lifted its holdings in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Addus HomeCare by 136.5% during the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock worth $9,294,000 after acquiring an additional 46,199 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in Addus HomeCare by 90.6% during the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock valued at $2,136,000 after acquiring an additional 8,743 shares in the last quarter. 95.35% of the stock is owned by institutional investors.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- 3 Monster Growth Stocks to Buy Now
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- How to Capture the Benefits of Dividend Increases
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.